Page 18 - ITPS-7-2
P. 18

INNOSC Theranostics and
            Pharmacological Sciences                                             Novel pharmacologic therapies for SAH



            Availability of data                               10.  van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage.
                                                                  Lancet. 2007;369:306-318.
            Not applicable.
                                                                  doi: 10.1016/S0140-6736(07)60153-6
            References                                         11.  Bonita R, Thomson S. Subarachnoid hemorrhage:

            1.   Lai PMR, Du R. Association between s100b levels and long-  Epidemiology, diagnosis, management, and outcome.
               term outcome after aneurysmal subarachnoid hemorrhage:   Stroke. 1985;16:591-594.
               Systematic review and pooled analysis.  PLoS One.      doi: 10.1161/01.str.16.4.591
               2016;11:e0151853.
                                                               12.  Claassen J, Park S. Spontaneous subarachnoid haemorrhage.
               doi: 10.1371/journal.pone.0151853                  Lancet. 2022;400:846-862.
            2.   Su XW, Chan AHY, Lu G, et al. Circulating microrna 132-     doi: 10.1016/S0140-6736(22)00938-2
               3p and 324-3p profiles in patients after acute aneurysmal   13.  Ronchetti G, Morales-Valero SF, Lanzino G, Wald JT. A cause
               subarachnoid hemorrhage. PLoS One. 2015;10:e0144724.
                                                                  of atypical intracranial subarachnoid hemorrhage: Posterior
               doi: 10.1371/journal.pone.0144724                  spinal artery aneurysms. Neurocrit Care. 2015;22:299-305.
            3.   Ziu  E,  Khan  Suheb  MZ,  Mesfin  FB.  Subarachnoid      doi: 10.1007/s12028-014-0009-5
               hemorrhage. In: StatPearls. Treasure Island, FL: StatPearls   14.  Olsen MH, Lilja-Cyron A, Bache S, Eskesen V, Møller
               Publishing; 2023. Available from: https://www.ncbi.nlm.nih.  K. Aneurismal subaraknoidalblødning.  Ugeskr Laeger.
               gov/books/NBK441958 [Last accessed on 2023 Jun 01].  2019;181:V01190019.
            4.   Grandhi R, Kottenmeier E, Cameron HL, Kane ST, Taussky   15.  Macdonald RL, Schweizer TA. Spontaneous subarachnoid
               P. Influence of neurovascular embolic coil primary wind   haemorrhage. Lancet. 2017;389:655-666.
               diameter on aneurysm packing density and case costs. J Med
               Econ. 2021;24:345-351.                             doi: 10.1016/S0140-6736(16)30668-7
               doi: 10.1080/13696998.2021.1885194              16.  Al-Shahi R, White PM, Davenport RJ, Lindsay KW.
                                                                  Subarachnoid haemorrhage. BMJ. 2006;333:235-240.
            5.   Hwong WY, Ang SH, Bots ML,  et al. Trends of stroke
               incidence and 28-day all-cause mortality after a stroke in      doi: 10.1136/bmj.333.7561.235
               Malaysia: A linkage of national data sources.  Glob Heart,   17.  Hutton CF. Subarachnoid haemorrhage.  Br J Radiol.
               2021;16:39.                                        1954;27:471-472.
               doi: 10.5334/gh.791                                doi:  10.1259/0007-1285-27-320-471
            6.   Cai YY, Zhuang YK, Wang WJ, et al. Potential role of serum   18.  Richardson A.  Subarachnoid  haemorrhage.  Br  Med  J.
               hypoxia-inducible factor 1alpha as a biomarker of delayed   1969;4:89-92.
               cerebral ischemia and poor clinical outcome after human      doi: 10.1136/bmj.4.5675.89
               aneurysmal subarachnoid hemorrhage: A prospective,
               longitudinal, multicenter, and observational study.  Front   19.  Jolobe  OM.  Subarachnoid  haemorrhage.  Lancet.
               Neurol. 2022;13:1072351.                           2007;369:904.
               doi: 10.3389/fneur.2022.1072351                    doi: 10.1016/S0140-6736(07)60443-7
            7.   Koseki H, Aoki T. Population of inflammatory cells   20.  Long B, Koyfman A, Runyon MS. Subarachnoid hemorrhage:
               in intracranial aneurysm with the special insight to   Updates in diagnosis and management.  Emerg Med Clin
               the development of novel diagnostic and therapeutic   North Am. 2017;35:803-824.
               approaches. Neuroimmunol Neuroinflamm. 2016;3:173.     doi: 10.1016/j.emc.2017.07.001
               doi: 10.20517/2347-8659.2016.05                 21.  Vivancos J, Gilo F, Frutos R,  et al. Clinical management
            8.   Xing L, Long H, Bo R, Gou X, He Y, Peng X. A computational   guidelines  for  subarachnoid  haemorrhage.  Diagnosis  and
               model of blood d-dimer, cystatin C, and CRP levels predicts   treatment. Neurologia. 2014;29:353-370.
               the risk of intracranial aneurysms and their rupture.      doi: 10.1016/j.nrl.2012.07.009
               Computat Intell Neurosci. 2022;2022:2216509.
                                                               22.  Moore SA, Rabinstein AA, Stewart MW, Freeman  D.
               doi: 10.1155/2022/2216509                          Recognizing the signs and symptoms of aneurysmal
            9.   Cikla U, Aagaard-Kienitz B, Turski PA, Menekse G, Niemann   subarachnoid  hemorrhage.  Expert  Rev  Neurother.
               DB, Başkaya MK. Familial perimesencephalic subarachnoid   2014;14:757-768.
               hemorrhage: Two case reports. J Med Case Rep. 2014;8:380.     doi: 10.1586/14737175.2014.922414
               doi: 10.1186/1752-1947-8-380                    23.  Larson AS, Brinjikji W. Subarachnoid hemorrhage


            Volume 7 Issue 2 (2024)                         12                               doi: 10.36922/itps.2019
   13   14   15   16   17   18   19   20   21   22   23